http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1265527-A2
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c3c9fc3cb0028234aedb8df651f9d2e4 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d3a1fbf1dce23cb388b673d1ab23a3fc |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M5-1483 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K49-1815 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01R33-5601 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-416 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-055 |
| classificationIPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61M5-148 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01R33-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K49-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K49-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B5-055 |
| filingDate | 2001-03-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_41856467060d4527eda7ae75e55f6f78 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b591d51b444487ad4c39d41512f5f7e0 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f954cfdd320f66e2e52ba1117facfdd1 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e8bc2346dd0105f5975dd79528e3e75b |
| publicationDate | 2002-12-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | EP-1265527-A2 |
| titleOfInvention | Diagnostic procedures using direct injection of gaseous hyperpolarized ?129 xe and associated systems and products |
| abstract | A method of screening for pulmonary embolism uses gaseous phase polarized Xe-129 which is injected directly into the vasculature of a subject. The gaseous Xe-129 can be delivered in a controlled manner such that the gas substantially dissolves into the vasculature proximate to the injection site. The injectable formulation of polarized Xe-129 gas is presented in small quantities of (preferably isotopically enriched) hyperpolarized Xe-129 and can provide high-quality vasculature MRI images or NMR spectroscopic signals with clinically useful signal resolution or intensity. The direct injection of small quantities of gas at particular sites along the vasculature targets specific target regions to provide increased signal intensity NMR images. The disclosure also includes related methods directed to other diagnostic vasculature regions physiological and conditions. Associated delivery and dispensing systems and methods, containers, and quantitative formulations of the polarized gas are also described. |
| priorityDate | 2000-03-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 27.